Related Experiment Video
Updated: May 8, 2026
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Development of Non-Invasive Biosensors for Neonatal Jaundice Detection: A Review
Chandan Jyoti Hazarika1, Alee Borah1, Poly Gogoi1
1Department of Biomedical Engineering, North-Eastern Hill University, Shillong, Meghalaya 793022, India.
Insights
Neonatal jaundice, a common infant condition, can be detected non-invasively using biosensors. While promising, these biosensors require further development for clinical use.
Area of Science:
- Biomedical Engineering
- Neonatal Medicine
- Diagnostic Technology
Background:
- Neonatal jaundice, characterized by elevated bilirubin levels, affects many infants and can cause neurological damage if untreated.
- Traditional diagnosis relies on invasive blood tests, prompting research into alternative methods.
- Non-invasive biosensors offer a potential alternative for early and accessible jaundice detection.
Purpose of the Study:
- To systematically review the advancements in non-invasive biosensors for neonatal jaundice detection.
- To assess the current state and limitations of existing diagnostic modalities for neonatal jaundice.
- To identify challenges and future research directions for non-invasive biosensor development.
Main Methods:
- Systematic literature review of invasive and non-invasive diagnostic methods for neonatal jaundice.
- Analysis of current research and development in non-invasive biosensor technology.
- Evaluation of pre-clinical and in vitro studies on biosensor efficacy.
Main Results:
- Non-invasive biosensor technology for neonatal jaundice is in its nascent stages, primarily in pre-clinical and in vitro settings.
- Existing diagnostic methods, both invasive and non-invasive, have documented limitations.
- Significant challenges remain, including the need for extensive validation, user-friendly designs, and regulatory approval.
Conclusions:
- Non-invasive biosensors hold revolutionary potential for neonatal jaundice diagnosis.
- Further research is crucial to enhance precision, affordability, and user-friendliness of these devices.
- Addressing validation, cost, and regulatory hurdles is essential for clinical implementation.
Abstract:
One of the most common problems many babies encounter is neonatal jaundice. The symptoms are yellowing of the skin or eyes because of bilirubin (from above 2.0 to 2.5 mg/dL in the blood). If left untreated, it can lead to serious neurological complications. Traditionally, jaundice detection has relied on invasive blood tests, but developing non-invasive biosensors has provided an alternative approach. This systematic review aims to assess the advancement of these biosensors. This review discusses the many known invasive and non-invasive diagnostic modalities for detecting neonatal jaundice and their limitations. It also notes that the recent research and development on non-invasive biosensors for neonatal jaundice diagnosis is still in its early stages, with the majority of investigations being in vitro or at the pre-clinical level. Non-invasive biosensors could revolutionize neonatal jaundice detection; however, a number of issues still need to be solved before this can happen. These consist of in-depth validation studies, affordable and user-friendly gadgets, and regulatory authority approval. To create biosensors that meet regulatory requirements, additional research is required to make them more precise and affordable.
